Stay tuned for more information on the next BioChallenge competition, which will launch in Summer 2017!
The 5th Annual BioChallenge Startup Competition
The Center supports Louisiana life sciences entrepreneurs through the BioChallenge, an annual competition that has awarded startups nearly $100,000 in prizes since 2012.
Following the 2016 Louisiana University Technology Showcase, four finalists will pitch for more than $50,000 in prizes on November 16 in downtown New Orleans.
Grand Prize: $25,000
New Orleans BioFund Prize: $25,000 investment
The Conafay Group Audience Favorite Prize: $2,500
Finalists are eligible to win any or all of the three prizes.
**Note: The New Orleans BioFund prize is contingent on a due diligence process and approval by both company and the BioFund. Learn more about the prize here.
|Carre BioDiagnostics (New Orleans) aims to treat and prevent cardiovascular diseases in chronic kidney disease patients. Carre is initially focused on a simple diagnostic blood test to identify chronic kidney disease patients with coronary artery disease who are at high risk for heart attacks, allowing for earlier treatment, improved outcomes and reduced costs.||Grapheno (Shreveport) develops innovative graphene solutions. The company’s first product is a conductive coating based on graphene which protects sensitive electronics in various industries by absorbing harmful and unnecessary electromagnetic radiation. It is a low-cost alternative that meets or exceeds the protection levels of existing solutions.|
|Chosen Diagnostics (New Orleans) is improving healthcare delivery for patients by personalizing their treatment. The company’s first product is a biomarker test to diagnose a common and life-threatening gastrointestinal disease in preterm infants, offering more accurate results than current options and allowing earlier intervention in these fragile patients.||Segue Therapeutics (Shreveport) is an early-stage privately owned biotech company dedicated to the discovery and medical use of repurposed drugs, or the application of approved drugs to new disease indications. Segue first aims to treat pancreatic cancer, a devastating disease for which truly effective life-extending treatments are not currently available.|
Final Pitch Event
Wednesday, November 16
The Joy Theater, 1200 Canal Street
11:00 am – 1:00pm
Our final pitch competition judges include industry experts and national investors:
- Faz K. Bashi, MD, Life Science Angels
- Sandra I. Coufal, MD, Sibling Capital LLC
- Joe Lovett, Louisiana Funds
- Dale Pfost, PhD, Advent Life Sciences
- Tamara StClaire, Xerox Healthcare
- Rob Tucci, Houston Angel Network
Thanks to our sponsors: